search
Back to results

Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention

Primary Purpose

Obesity, Overweight, Weight Loss

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Core behavioral weight loss intervention
Self-monitoring diet
Self-monitoring weight
Self-monitoring steps
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring digital health, mobile health, intervention, weight loss, behavioral treatment, Multiphase Optimization Strategy (MOST), obesity treatment, dietary change, physical activity, self-monitoring, factorial design

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • adults (ages 18+ years)
  • body mass index (BMI) 25.0 to 45.0 kg/m^2
  • smartphone ownership
  • willingness to install a mobile app on their phone
  • access to a personal email account
  • English language proficiency
  • interest in losing weight through behavioral strategies

Exclusion Criteria:

  • concurrent enrollment in another weight management intervention
  • loss of ≥10 lbs. in the past 6 months
  • current use of a weight loss medication
  • prior or planned bariatric surgery
  • current or planned pregnancy in the trial period
  • currently breastfeeding
  • lives with someone else participating in the study
  • hospitalization for a mental health condition in the past 12 months
  • inability to engage in moderate forms of physical activity akin to brisk walking (assessed by the Physical Activity Readiness Questionnaire)
  • if weight loss is contraindicated or might be impacted by a condition or medication (e.g., end stage renal disease, cancer, schizophrenia, dementia, steroids, anti-psychotics)
  • if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus)
  • investigator discretion for safety reasons

Sites / Locations

  • Stanford University School of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Condition 1

Condition 2

Condition 3

Condition 4

Condition 5

Condition 6

Condition 7

Condition 8

Arm Description

Core Only

Core + Track Weight

Core + Track Steps

Core + Track Diet

Core + Track Weight + Track Steps

Core + Track Weight + Track Diet

Core + Track Steps + Track Diet

Core + Track Weight + Track Steps + Track Diet

Outcomes

Primary Outcome Measures

Body weight change from baseline to 6 months
change in weight from baseline to 6-month followup; assessed objectively via e-scale

Secondary Outcome Measures

Body weight from baseline to 1 month
change in weight from baseline to 1-month followup; assessed objectively via e-scale
Body weight from baseline to 3 months
change in weight from baseline to 3-month followup; assessed objectively via e-scale
Clinically significant weight loss
proportion of participants achieving ≥5% weight loss from baseline
BMI change from baseline to 6 months
change in BMI from baseline to 6-month followup; computed from self-reported height and e-scale weight
Caloric intake change from baseline to 6 months
change in caloric intake from baseline to 6-month followup; assessed using Automated 24-Hour (ASA-24) Dietary Assessment Tool (2 separate 24hr diet recalls at each time point: 1 week day, 1 weekend day)
Physical activity change from baseline to 6 months
change in physical activity from baseline to 6-month followup; assessed using Godin Leisure-Time Exercise Questionnaire
Engagement in self-monitoring dietary intake
average percent of days in the 6-month intervention of self-monitoring dietary intake; assessed objectively via digital health tools (mobile app)
Engagement in self-monitoring weight
average percent of days in the 6-month intervention of self-monitoring weight; assessed objectively via digital health tools (e-scale)
Engagement in self-monitoring steps
average percent of days in the 6-month intervention of self-monitoring steps; assessed objectively via digital health tools (activity monitor)

Full Information

First Posted
February 10, 2022
Last Updated
September 22, 2023
Sponsor
Stanford University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
search

1. Study Identification

Unique Protocol Identification Number
NCT05249465
Brief Title
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
Official Title
Optimizing Self-monitoring in a Digital Health Intervention for Weight Loss
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 22, 2023 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This optimization trial will examine three tracking (or "self-monitoring") strategies for weight loss -- tracking dietary intake, steps, and/or body weight -- all delivered through digital health tools. The purpose of the study is to evaluate the combination of these strategies that maximizes 6-month weight loss in the context of a standalone digital health intervention for adults with overweight or obesity. The investigators will recruit 176 total participants to the trial. Recruitment will occur through remote channels. Interested individuals will be directed to an online screening questionnaire; those who are eligible will then be invited to attend an initial remote session with study personnel to ensure interest and eligibility in the study. The weight loss intervention will last 6 months, and all participants will receive a "core" treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely. Depending on which group participants are assigned to in the study, some individuals will be asked to track their dietary intake, their steps, and/or their body weight via digital tools. All study tasks will occur remotely, thus, participants never need to come in-person for any intervention or assessment tasks. The investigators will use the Multiphase Optimization Strategy (MOST) framework to identify the most effective combination of self-monitoring strategies. The factorial design will allow the research team to determine the unique and combined impact of each self-monitoring component on weight change. The primary outcome is weight change from baseline to 6 months. The research team will also assess self-monitoring engagement over 6 months and its association with weight change. To complement the main trial, the research team will also randomize half of participants to receive an interactive orientation video, in order to assess its impact on trial retention at 6 months. Overall, the information gathered from this trial will enable the construction of an optimized digital health intervention for weight loss that can be delivered remotely, which, if found to be effective, could have high potential for scalability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Overweight, Weight Loss, Health Behavior
Keywords
digital health, mobile health, intervention, weight loss, behavioral treatment, Multiphase Optimization Strategy (MOST), obesity treatment, dietary change, physical activity, self-monitoring, factorial design

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
This study uses a full factorial experimental design testing the efficacy of three intervention components, each with two levels (i.e., a 2x2x2).
Masking
None (Open Label)
Masking Description
Outcomes will be analyzed in a blinded fashion such that treatment allocation is not revealed.
Allocation
Randomized
Enrollment
176 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Condition 1
Arm Type
Experimental
Arm Description
Core Only
Arm Title
Condition 2
Arm Type
Experimental
Arm Description
Core + Track Weight
Arm Title
Condition 3
Arm Type
Experimental
Arm Description
Core + Track Steps
Arm Title
Condition 4
Arm Type
Experimental
Arm Description
Core + Track Diet
Arm Title
Condition 5
Arm Type
Experimental
Arm Description
Core + Track Weight + Track Steps
Arm Title
Condition 6
Arm Type
Experimental
Arm Description
Core + Track Weight + Track Diet
Arm Title
Condition 7
Arm Type
Experimental
Arm Description
Core + Track Steps + Track Diet
Arm Title
Condition 8
Arm Type
Experimental
Arm Description
Core + Track Weight + Track Steps + Track Diet
Intervention Type
Behavioral
Intervention Name(s)
Core behavioral weight loss intervention
Intervention Description
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Intervention Type
Behavioral
Intervention Name(s)
Self-monitoring diet
Intervention Description
Participants randomized to receive this component will be instructed to self-monitor their dietary intake daily via the Fitbit mobile app. Participants will receive a daily calorie goal.
Intervention Type
Behavioral
Intervention Name(s)
Self-monitoring weight
Intervention Description
Participants randomized to receive this component will be instructed to self-monitor their body weight daily via a wireless e-scale (e.g., the Fitbit Aria Scale).
Intervention Type
Behavioral
Intervention Name(s)
Self-monitoring steps
Intervention Description
Participants randomized to receive this component will be instructed to self-monitor their step count daily via a wrist-worn Fitbit activity monitor. A daily step goal will be given that will adapt based on progress.
Primary Outcome Measure Information:
Title
Body weight change from baseline to 6 months
Description
change in weight from baseline to 6-month followup; assessed objectively via e-scale
Time Frame
baseline and 6 months
Secondary Outcome Measure Information:
Title
Body weight from baseline to 1 month
Description
change in weight from baseline to 1-month followup; assessed objectively via e-scale
Time Frame
baseline, 1 month
Title
Body weight from baseline to 3 months
Description
change in weight from baseline to 3-month followup; assessed objectively via e-scale
Time Frame
baseline, 3 month
Title
Clinically significant weight loss
Description
proportion of participants achieving ≥5% weight loss from baseline
Time Frame
6 months
Title
BMI change from baseline to 6 months
Description
change in BMI from baseline to 6-month followup; computed from self-reported height and e-scale weight
Time Frame
baseline, 6 months
Title
Caloric intake change from baseline to 6 months
Description
change in caloric intake from baseline to 6-month followup; assessed using Automated 24-Hour (ASA-24) Dietary Assessment Tool (2 separate 24hr diet recalls at each time point: 1 week day, 1 weekend day)
Time Frame
baseline, 6 months
Title
Physical activity change from baseline to 6 months
Description
change in physical activity from baseline to 6-month followup; assessed using Godin Leisure-Time Exercise Questionnaire
Time Frame
baseline, 6 months
Title
Engagement in self-monitoring dietary intake
Description
average percent of days in the 6-month intervention of self-monitoring dietary intake; assessed objectively via digital health tools (mobile app)
Time Frame
baseline to 6 months
Title
Engagement in self-monitoring weight
Description
average percent of days in the 6-month intervention of self-monitoring weight; assessed objectively via digital health tools (e-scale)
Time Frame
baseline to 6 months
Title
Engagement in self-monitoring steps
Description
average percent of days in the 6-month intervention of self-monitoring steps; assessed objectively via digital health tools (activity monitor)
Time Frame
baseline to 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adults (ages 18+ years) body mass index (BMI) 25.0 to 45.0 kg/m^2 smartphone ownership willingness to install a mobile app on their phone access to a personal email account English language proficiency interest in losing weight through behavioral strategies Exclusion Criteria: concurrent enrollment in another weight management intervention loss of ≥10 lbs. in the past 6 months current use of a weight loss medication prior or planned bariatric surgery current or planned pregnancy in the trial period currently breastfeeding lives with someone else participating in the study hospitalization for a mental health condition in the past 12 months inability to engage in moderate forms of physical activity akin to brisk walking (assessed by the Physical Activity Readiness Questionnaire) if weight loss is contraindicated or might be impacted by a condition or medication (e.g., end stage renal disease, cancer, schizophrenia, dementia, steroids, anti-psychotics) if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus) investigator discretion for safety reasons
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michele L Patel, PhD
Phone
650-549-7047
Email
michele.patel@stanford.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michele L Patel, PhD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michele L Patel, PhD
First Name & Middle Initial & Last Name & Degree
Abby C King, PhD
First Name & Middle Initial & Last Name & Degree
Lisa G Rosas, PhD, MPH

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Once the study data have undergone final data cleaning, analysis, and planned publications, the investigators will make the final data collected as part of the proposed research available in electronic form to researchers who request them. Researchers will be asked to submit a data request in writing to the Principal Investigator so that the requested data can be made available while protecting the confidentiality of study participants and ensuring that the proposed research questions do not overlap with planned publication development by the project research team or other groups. The requested dataset will be free of identifiers that would permit linkages to individual research participants. The requestor must agree to maintain the privacy and confidentiality of the data and must indicate how they plan to store the data to demonstrate compliance with secure computing. All publications that emerge from this award will be publicly available via PubMed Central.

Learn more about this trial

Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention

We'll reach out to this number within 24 hrs